Skip to main content
. 2020 Dec 11;2020:2872479. doi: 10.1155/2020/2872479

Figure 4.

Figure 4

Kaplan–Meier curves for overall survival of ESCC with FGF2, FGFR3, and FGFBP1 expression. (a) Patients expressing high level of FGF2 have a significantly shorter survival (p < 0.001); (b) patients expressing high level of FGFR3 have a significantly shorter survival (p < 0.001); (c) patients expressing high level of FGFBP1 have a significantly shorter survival (p < 0.001).